-transparent.png){kind=logo}
A randomised trial was undertaken in one hundred patients with heart failure and/or chest infection to determine whether low-dose subcutaneous heparin induced the frequency of deep vein thrombosis (DVT) in the legs. Heparin, (5000 units 8 hourly) significantly reduced the frequency of DVT, diagnosed by the 125I-fibrinogen scan technique, from 26 to 4 per cent (p less than 0.01). Heparin was started within 12 hours of admission to hospital and continued until the patient was fully mobile. Heparin did not cause bleeding problems except for a 20 per cent incidence of injection site bruising. We therefore recommend prophylaxis with low-dose subcutaneous heparin in patients with heart failure or chest infection who require more than three days bed rest.
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
June 1987,
Scottish medical journal,
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
July 1985,
Journal of the Royal Society of Medicine,
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
November 1972,
Drug and therapeutics bulletin,
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
October 1974,
Lancet (London, England),
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
January 1980,
Urological research,
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
December 1973,
Lancet (London, England),
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
January 1985,
The Netherlands journal of medicine,
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
April 1973,
The Medical letter on drugs and therapeutics,
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
January 1982,
Phlebologie,
J J Belch, and
G D Lowe, and
A G Ward, and
C D Forbes, and
C R Prentice
April 1980,
Lancet (London, England),
